HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qidong You Selected Research

Kv1.5 Potassium Channel

12/2022Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors.
6/2014Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).
9/2008Modeling the binding modes of Kv1.5 potassium channel and blockers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qidong You Research Topics

Disease

75Neoplasms (Cancer)
01/2022 - 08/2006
17Breast Neoplasms (Breast Cancer)
11/2019 - 01/2009
9Hypoxia (Hypoxemia)
05/2020 - 07/2015
9Hepatocellular Carcinoma (Hepatoma)
08/2013 - 08/2006
6Neoplasm Metastasis (Metastasis)
04/2017 - 01/2009
5Inflammation (Inflammations)
03/2020 - 05/2009
4Cardiac Arrhythmias (Arrythmia)
12/2022 - 04/2007
4Anemia
10/2020 - 01/2017
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2011
3Atrial Fibrillation
12/2022 - 09/2008
3Leukemia
01/2021 - 11/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2020 - 02/2018
3Prostatic Neoplasms (Prostate Cancer)
10/2019 - 01/2014
3Carcinoma (Carcinomatosis)
06/2015 - 11/2012
2Carcinogenesis
05/2020 - 01/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018 - 09/2017
2Glioma (Gliomas)
11/2015 - 10/2013
1Lung Neoplasms (Lung Cancer)
09/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2021
1Experimental Arthritis
11/2020
1Rheumatoid Arthritis
11/2020
1Bacterial Infections (Bacterial Infection)
03/2019
1Malaria
03/2019
1Acquired Immunodeficiency Syndrome (AIDS)
03/2019
1Fibrosis (Cirrhosis)
03/2019
1B-Cell Leukemia (Leukemia, B Cell)
02/2019
1Cardiovascular Diseases (Cardiovascular Disease)
10/2018

Drug/Important Bio-Agent (IBA)

16wogoninIBA
11/2019 - 08/2006
13Pharmaceutical PreparationsIBA
01/2021 - 12/2010
12gambogic acidIBA
04/2017 - 10/2008
10Proteins (Proteins, Gene)FDA Link
08/2021 - 10/2008
10Biological ProductsIBA
05/2020 - 09/2008
10FlavonoidsIBA
11/2016 - 05/2009
85,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
11/2015 - 01/2009
6EnzymesIBA
03/2019 - 09/2013
6Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019 - 05/2014
5Phosphotransferases (Kinase)IBA
01/2022 - 10/2013
5TamoxifenFDA LinkGeneric
01/2019 - 09/2009
5Selective Estrogen Receptor Modulators (SERM)IBA
01/2019 - 09/2009
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2017
4Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
05/2020 - 12/2015
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 06/2009
4Messenger RNA (mRNA)IBA
01/2019 - 12/2011
4Estrogen ReceptorsIBA
01/2018 - 05/2014
4CateninsIBA
11/2016 - 10/2013
3Kv1.5 Potassium ChannelIBA
12/2022 - 09/2008
3ProdrugsIBA
11/2020 - 10/2017
3Prolyl-Hydroxylase InhibitorsIBA
10/2020 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
10/2020 - 10/2017
3XanthonesIBA
10/2017 - 04/2011
3Potassium Channels (Potassium Channel)IBA
01/2014 - 04/2007
3PiperazineIBA
01/2014 - 01/2009
3xanthoneIBA
11/2012 - 12/2011
2Hormones (Hormone)IBA
01/2022 - 09/2009
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2022 - 01/2020
2Protein Kinases (Protein Kinase)IBA
01/2022 - 01/2014
2Adenosine Triphosphatases (ATPase)IBA
10/2021 - 01/2021
2Therapeutic UsesIBA
11/2020 - 01/2009
2ErythropoietinFDA Link
10/2020 - 01/2017
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2019 - 04/2011
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 08/2006
2quinone (benzoquinone)IBA
12/2018 - 01/2018
2NAD (NADH)IBA
12/2018 - 01/2018
2Paclitaxel (Taxol)FDA LinkGeneric
12/2018 - 10/2017
2Oxidoreductases (Dehydrogenase)IBA
12/2018 - 01/2018
2LigandsIBA
04/2018 - 11/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 01/2017
2Raloxifene Hydrochloride (Evista)FDA Link
01/2018 - 09/2009
2Dihydrotestosterone (Androstanolone)IBA
01/2017 - 01/2014
2wogonosideIBA
11/2016 - 05/2009
2beta-lapachoneIBA
03/2016 - 07/2014
2Annexin A5IBA
03/2014 - 11/2008
2Type I DNA Topoisomerases (Topoisomerase I)IBA
05/2013 - 01/2009
2LYG 202IBA
06/2011 - 01/2010
1SteroidsIBA
01/2022
1RibonucleoproteinsIBA
01/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2021
1Peptides (Polypeptides)IBA
09/2021
1HydrocarbonsIBA
09/2021
1Methylcellulose (BFL)IBA
08/2021
1venetoclaxIBA
08/2021
1Serine (L-Serine)FDA Link
01/2021
1MethyltransferasesIBA
01/2021
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
01/2021
1Threonine (L-Threonine)FDA Link
01/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021
1AndrogensIBA
10/2019
1ImidazolesIBA
10/2019
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
10/2019
1MetalsIBA
03/2019
1pyrimidineIBA
02/2019
1Oxygen (Dioxygen)IBA
01/2019
1PyrimidinesIBA
04/2018
1Proteolysis Targeting ChimeraIBA
02/2018

Therapy/Procedure

20Therapeutics
09/2021 - 05/2008
2Oral Administration
01/2021 - 10/2020
2Intravenous Injections
07/2011 - 03/2009
1Aftercare (After-Treatment)
04/2018